Justin Chakma, Chief Business Officer at ARS Pharmaceuticals, Inc. (SPRY), sold 289,210 shares at $12.06 ($3.5M) on 2024-12-13, disclosed to the SEC on 2024-12-13.
Open-market sale of $3.5M SPRY by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.27 | 117,333 | $1.4M | 40.7% |
| 2 | $12.27 | 117,333 | $1.4M | 40.7% |
| 3 | $12.06 | 27,272 | $329K | 9.3% |
| 4 | $12.06 | 27,272 | $329K | 9.3% |
| Total | $12.23 avg | 289,210 | $3.5M | 100% |
| Filing → |
| SPRY | SELL | 2024-12-06 | $2.7M | — | Filing → |
| SPRY | SELL | 2024-12-04 | $1.2M | — | Filing → |
| SPRY | SELL | 2024-11-27 | $2.0M | — | Filing → |